China NMPA Product Recall - Medical image processing software

On March 13, 2020, Philips (China) Investment Co., Ltd. initiated a voluntary Class III recall of its Intellispace Portal medical image processing software. This action was prompted by a discrepancy identified in the product's labeling and instructions, where the medical device registration certificate number had not been updated to reflect a recent change in the certificate for Intellispace Portal. The recall was reported through the National Medical Products Administration (NMPA) framework, specifically by the Shanghai Municipal Drug Administration. Philips (China) identified that while the core medical device registration certificate for the Intellispace Portal was updated, corresponding updates were not consistently applied to all product labels and instructional materials. It is important to note that Philips (China) explicitly stated that this labeling inconsistency is unrelated to any health risks for patients or users of the software. The recall is a corrective action to ensure accuracy and compliance with regulatory documentation standards. Detailed information regarding the specific models, specifications, and batches affected by this recall was provided in a "Medical Device Recall Event Report Form" attachment, indicating a structured approach to addressing the identified non-conformity. This proactive measure by Philips (China) underscores its commitment to regulatory adherence under the NMPA's oversight.